Healthy Returns: AbbVie is the newest potential weight loss drug market player

• 

  Novo’s Weight Loss Drugs Removed from FDA Shortage List

  The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list.
  
  Inc. - Feb. 22
• 

  Drug compounders sue over weight loss drugs' removal from FDA shortage list

  A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...
  
  The Hill - Feb. 25

• From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

  Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
  
  CNBC - Feb. 20

• Why Walmart’s warning may have more to do with weight-loss drugs than tariffs

  Walmart’s stock fell Thursday as quarterly earnings were expected to decline for the first time in three years, with strength in groceries and GLP-1 drug sales continuing to pressure margins.
  
  MarketWatch - Feb. 21

• Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

  Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.
  
  CNBC - Feb. 24
• 

  We know so little about taking weight-loss drugs without prescription – is it really worth it? | Devi Sridhar

  Studies show that they’re effective for overweight people, but if you’re healthy, there are less risky ways to lose weight. When I’ve been in the gym over the past few months, one of the things ...
  
  The Guardian - Feb. 25

• Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

  Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.
  
  CNBC - Feb. 25

• Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

  The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.
  
  MarketWatch - 6d

• Viní Jr excited for Neymar's potential Brazil return

  Vinícius Júnior has said he is excited about the possibility of Neymar returning to the Brazil squad for their upcoming World Cup qualifiers.
  
  ESPN - 4h

More from CNBC

• Trump could scale back Canada, Mexico tariffs Wednesday, Lutnick says

  Commerce Secretary Howard Lutnick said a compromise with Canada and Mexico on Trump's controversial tariffs will "probably" come "tomorrow."
  
  CNBC - 6m

• Stagflation fears bubble up as Trump tariffs take effect and the economy slows

  A growth scare in the economy has accompanied worries over a resurgence in inflation, threatening to potentially rekindle stagflation.
  
  CNBC - 1h

• Canada, Mexico tariffs create 'ripple effects' on consumer prices, economist says

  Tariffs on the two largest trading partners of the United States are expected to have far-reaching impacts that may be hard to predict.
  
  CNBC - 2h

• Trump's tariffs showcase his extraordinary presidential power — and its limitations

  President Donald Trump's 25% tariffs on imports from Canada and Mexico took effect Tuesday. But actually collecting them is proving complicated.
  
  CNBC - 5h

• CFPB drops lawsuit against JPMorgan Chase, Bank of America and Wells Fargo over Zelle fraud

  Since Acting Director Russell Vought has taken over the CFPB, the agency has dropped at least a half dozen cases brought by his predecessor, Rohit Chopra.
  
  CNBC - 1h

More in Business

• Trump could scale back Canada, Mexico tariffs Wednesday, Lutnick says

  Commerce Secretary Howard Lutnick said a compromise with Canada and Mexico on Trump's controversial tariffs will "probably" come "tomorrow."
  
  CNBC - 6m

• Americans are racing to prep for tariffs, but many aren’t ready — especially this group

  The sweeping tariffs that President Donald Trump has been talking about since he was on the campaign trail are finally here, and they’re arriving at a tough time for many Americans.
  
  MarketWatch - 20m

• Fallout from Trump’s trade war is spilling over into corporate bonds at a crucial moment

  The first two weeks of March tend to see the highest bond issuance of the year for highly rated corporations.
  
  MarketWatch - 27m

• S&P 500 wipes out postelection gains, Nasdaq flirts with correction on tariff fears

  The tech-heavy Nasdaq Composite flirted with correction territory — defined as a drop of 10% from a recent high — on Tuesday, before trimming losses.
  
  MarketWatch - 33m
• 

  This Startup Just Raised $50 Million to Make Next-Gen Solar Panels

  Tandem PV has a bright idea: Develop solar panels that are both thinner and more efficient.
  
  Inc. - 43m